ArticleProceedings of the National Academy of Sciences of the United States of America2024

Engineering bacteria for cancer immunotherapy by inhibiting IDO activity and reprogramming CD8+ T cell response.

Heng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.